Cardiology

Study finds no long-term cardiovascular benefit from aspirin in healthy older people, but highlights increased bleeding risk.

Wearables reveal unique activity and heart rate patterns in long COVID, showing promise as clinical biomarkers.

Semaglutide improves cardiovascular risk factors but raises health care costs, finds large multicentre cohort study.

CPAP therapy lowers cardiovascular risks in high-risk obstructive sleep apnoea patients, new multi-trial study finds.

Discover the higher risk of heart failure with pregabalin versus gabapentin in older adults. Read the full study findings.

Early cardiac rehabilitation did not improve function or rehospitalisation in severe heart failure, but mobility gains were seen.

Adults later diagnosed with cardiovascular disease show declining activity years before onset, highlighting the importance of lifelong exercise.

Tirzepatide improves outcomes in heart failure with obesity, with greatest physical benefits seen in those with higher BMI.